Computer-aided molecular design of 1H-imidazole-2,4-diamine derivatives as potential inhibitors of Plasmodium falciparum DHFR enzyme
- 5 June 2010
- journal article
- Published by Springer Nature in Journal of Molecular Modeling
- Vol. 17 (4) , 657-667
Abstract
Design and discovery of new potential inhibitors of Plasmodium falciparum dihydrofolate reductase (PfDHFR), equally active against both the wild-type and mutant strains, is urgently needed. In this study, a computer-aided molecular design approach that involved ab initio molecular orbital and density functional theory calculations, along with molecular electrostatic potential analysis, and molecular docking studies was employed to design 15 1H-imidazole-2,4-diamine derivatives as potential inhibitors of PfDHFR enzyme. Visual inspection of the binding modes of the compounds demonstrated that they all interact, via H-bond interactions, with key amino acid residues (Asp54, Ileu/Leu164, Asn/Ser108 and Ile14) similar to those of WR99210 (3) in the active site of the enzymes used in the study. These interactions are known to be essential for enzyme inhibition. These compounds showed better or comparable binding affinities to that of the bound ligand (WR99210). In silico toxicity predictions, carried out using TOPKAT software, also indicated that the compounds are non-toxic.Keywords
This publication has 57 references indexed in Scilit:
- Recent advances in computer-aided drug designBriefings in Bioinformatics, 2009
- Exploiting Structural Analysis, in Silico Screening, and Serendipity To Identify Novel Inhibitors of Drug-Resistant Falciparum MalariaACS Chemical Biology, 2009
- Novel ⊕N(←L)2 species with two lone pairs on nitrogen: systems isoelectronic to carbodicarbenesChemical Communications, 2009
- Novel Triazine JPC-2067-B Inhibits Toxoplasma gondii In Vitro and In VivoPLOS Neglected Tropical Diseases, 2008
- Computer-aided drug discovery and development (CADDD): In silico-chemico-biological approachChemico-Biological Interactions, 2008
- Conflicting Requirements of Plasmodium falciparum Dihydrofolate Reductase Mutations Conferring Resistance to Pyrimethamine-WR99210 CombinationAntimicrobial Agents and Chemotherapy, 2007
- Molecular dynamics of the interaction of Plasmodium falciparum and human serine hydroxymethyltransferase with 5-formyl-6-hydrofolic acid analogues: design of new potential antimalarialsJournal of the Brazilian Chemical Society, 2006
- Identification of Novel Parasitic Cysteine Protease Inhibitors by Use of Virtual Screening. 2. The Available Chemical DirectoryJournal of Medicinal Chemistry, 2006
- The global distribution of clinical episodes of Plasmodium falciparum malariaNature, 2005
- Accurate prediction of human drug toxicity: a major challenge in drug developmentChemico-Biological Interactions, 2004